SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Javier Crespo, Joaquín Cabezas, Begoña Sacristán, José L. Olcoz, Ramón Pérez, Juan De la Vega, Rosa García, Félix García-Pajares, Federico Sáez-Royuela, José M. González, Felipe Jiménez, Santiago Rodríguez, Antonio Cuadrado, María J. López-Arias, Isidro García, Ana Milla, Emilia García-Riesco, María Muñoz, Gloria Sánchez-Antolín, Francisco Jorquera, Barriers to HCV treatment in the era of triple therapy: a prospective multi-centred study in clinical practice, Liver International, 2014, 34, 6
  2. 2
    A. Lee, S. Liu, T. Wang, Identification of novel human kinases that suppress hepatitis C virus infection, Journal of Viral Hepatitis, 2014, 21, 8
  3. 3
    Do Young Kim, In Hee Kim, Sook-Hyang Jeong, Yong Kyun Cho, Joon Hyoek Lee, Young-Joo Jin, Don Lee, Dong Jin Suh, Kwang-Hyub Han, Neung Hwa Park, Ha Yan Kang, Young Kul Jung, Young Seok Kim, Kyung-Ah Kim, Youn Jae Lee, Byung Seok Lee, Hyung Joon Yim, Heon Ju Lee, Soon Koo Baik, Won Young Tak, Sun Jae Lee, Woo Jin Chung, Sung-Kyu Choi, Eun-Young Cho, Jeong Heo, Dong Joon Kim, Byung-Cheol Song, Man Woo Kim, Jun Lee, Hee Bok Chae, Dae Hee Choi, Hwa Young Choi, Moran Ki, A nationwide seroepidemiology of hepatitis C virus infection in South Korea, Liver International, 2013, 33, 4
  4. 4
    Emerson Y. Chen, Seth N. Sclair, Frank Czul, Betty Apica, Perry Dubin, Paul Martin, William M. Lee, A Small Percentage of Patients With Hepatitis C Receive Triple Therapy With Boceprevir or Telaprevir, Clinical Gastroenterology and Hepatology, 2013, 11, 8, 1014

    CrossRef

  5. You have free access to this content5
    A. H. Talal, J. LaFleur, R. Hoop, P. Pandya, P. Martin, I. Jacobson, J. Han, E. J. Korner, Absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C: results from a US database of over 45 000 HCV-infected, evaluated patients, Alimentary Pharmacology & Therapeutics, 2013, 37, 4
  6. 6
    Fabio Iacomi, Giuseppina Iannicelli, Andrea Franceschini, Paolo Migliorisi, Silvia Rosati, Pierluca Piselli, Paola Scognamiglio, Gabriella De Carli, Sonia Marcellini, Fabrizio Palmieri, HCV infected prisoners: should they be still considered a difficult to treat population?, BMC Infectious Diseases, 2013, 13, 1, 374

    CrossRef

  7. 7
    Carol S. North, Barry A. Hong, Sunday A. Adewuyi, David E. Pollio, Mamta K. Jain, Robert Devereaux, Nana A. Quartey, Sarah Ashitey, William M. Lee, Mauricio Lisker-Melman, Hepatitis C treatment and SVR: the gap between clinical trials and real-world treatment aspirations, General Hospital Psychiatry, 2013, 35, 2, 122

    CrossRef

  8. 8
    Maria Buti, Rafael Esteban, Preparing the patient for success: Treat or wait?, Digestive and Liver Disease, 2013, 45, S332

    CrossRef

  9. 9
    Gail Butt, Liza McGuinness, Terri Buller-Taylor, Sandi Mitchell, Reasons for Nonattendance across the Hepatitis C Disease Course, ISRN Nursing, 2013, 2013, 1

    CrossRef

  10. 10
    Christopher E. McGowan, Michael W. Fried, Barriers to hepatitis C treatment, Liver International, 2012, 32,
  11. 11
    Syed-Mohammed Jafri, Stuart C. Gordon, Care of the Cirrhotic Patient, Infectious Disease Clinics of North America, 2012, 26, 4, 979

    CrossRef

  12. 12
    R. Douglas Bruce, Julie Eiserman, Angela Acosta, Ceilia Gote, Joseph K. Lim, Frederick L. Altice, Developing a Modified Directly Observed Therapy Intervention for Hepatitis C Treatment in a Methadone Maintenance Program: Implications for Program Replication, The American Journal of Drug and Alcohol Abuse, 2012, 38, 3, 206

    CrossRef

  13. 13
    Thomas Astell-Burt, Robin Flowerdew, Paul Boyle, John Dillon, Is travel-time to a specialist centre a risk factor for non-referral, non-attendance and loss to follow-up among patients with hepatitis C (HCV) infection?, Social Science & Medicine, 2012, 75, 1, 240

    CrossRef

  14. 14
    Briana L. Calore, Ramsey C. Cheung, Nicholas J. Giori, Prevalence of Hepatitis C Virus Infection in the Veteran Population Undergoing Total Joint Arthroplasty, The Journal of Arthroplasty, 2012, 27, 10, 1772

    CrossRef

  15. 15
    Jason E. Bonner, A. Sidney Barritt, Michael W. Fried, Donna M. Evon, Tangible Resources for Preparing Patients for Antiviral Therapy for Chronic Hepatitis C, Digestive Diseases and Sciences, 2012, 57, 6, 1439

    CrossRef

  16. 16
    Jason E. Bonner, A. Sidney Barritt, Michael W. Fried, Donna M. Evon, Time to Rethink Antiviral Treatment for Hepatitis C in Patients with Coexisting Mental Health/Substance Abuse Issues, Digestive Diseases and Sciences, 2012, 57, 6, 1469

    CrossRef

  17. 17
    Stephen E. Livingston, Lisa J. Townshend-Bulson, Dana L. Bruden, Brian J. McMahon, Chriss E. Homan, James E. Gove, Heike Deubner, Michael G. Bruce, Renee F. Robinson, David R. Gretch, Treatment eligibility in Alaska Native and American Indian persons with hepatitis C virus infection, International Journal of Circumpolar Health, 2012, 71, 0

    CrossRef

  18. 18
    Adeel A. Butt, Kathleen McGinnis, Melissa Skanderson, Amy C. Justice, A Comparison of Treatment Eligibility for Hepatitis C Virus in HCV-Monoinfected Versus HCV/HIV-Coinfected Persons in Electronically Retrieved Cohort of HCV-Infected Veterans, AIDS Research and Human Retroviruses, 2011, 27, 9, 973

    CrossRef

  19. 19
    Catherine Rongey, Steven Asch, Sara J Knight, Access to care for vulnerable veterans with hepatitis C: a hybrid conceptual framework and a case study to guide translation, Translational Behavioral Medicine, 2011, 1, 4, 644

    CrossRef

  20. 20
    MICHAEL A. CUCCIARE, KENNETH R. WEINGARDT, Commentary on Gibson et al. (2011): Brief alcohol interventions in the context of treatment for hepatitis C, Addiction, 2011, 106, 12
  21. 21
    Jennifer R Kramer, Fasiha Kanwal, Peter Richardson, Thomas P Giordano, Laura A Petersen, Hashem B El-Serag, Importance of Patient, Provider, and Facility Predictors of Hepatitis C Virus Treatment in Veterans: A National Study, The American Journal of Gastroenterology, 2011, 106, 3, 483

    CrossRef

  22. 22
    Huei-Chen Lu, Kuo-Cherh Huang, Chi-Jen Chu, Influencing Factors of Healthcare-Seeking Behaviors in Taiwanese Patients With Hepatitis C, Gastroenterology Nursing, 2010, 33, 6, 414

    CrossRef

  23. 23
    Valerie Perut, Celine Labalette, Philippe Sogni, Isabelle Ferrand, Dominique Salmon-Céron, Gwenaelle Vidal-Trecan, Access to care of patients with chronic hepatitis C virus infection in a university hospital: Is opioid dependence a limiting condition?, Drug and Alcohol Dependence, 2009, 104, 1-2, 78

    CrossRef

  24. 24
    Randy A. Sansone, Jamie S. McLean, Michael W. Wiederman, Alcohol and substance misuse: relationship with medically self-sabotaging behaviors, General Hospital Psychiatry, 2009, 31, 5, 497

    CrossRef

  25. 25
    Adeel A. Butt, Joel Tsevat, Anthony C. Leonard, Obaid S. Shaikh, Deborah McMahon, Uzma A. Khan, Zachariah Dorey-Stein, Vincent Lo Re, Effect of race and HIV co-infection upon treatment prescription for hepatitis C virus, International Journal of Infectious Diseases, 2009, 13, 4, 449

    CrossRef

  26. 26
    Arne Schäfer, Hans-Ulrich Wittchen, Markus Backmund, Michael Soyka, Jörg Gölz, Jens Siegert, Martin Schäfer, Felix Tretter, Michael R. Kraus, Psychopathological changes and quality of life in hepatitis C virus-infected, opioid-dependent patients during maintenance therapy, Addiction, 2009, 104, 4
  27. 27
    A. J. Mitchell, D. Malone, C. C. Doebbeling, Quality of medical care for people with and without comorbid mental illness and substance misuse: systematic review of comparative studies, The British Journal of Psychiatry, 2009, 194, 6, 491

    CrossRef

  28. 28
    Adeel A. Butt, Uzma A. Khan, Melissa Skanderson, Comorbidities and Their Impact on Mortality in HCV and HCV-HIV–coinfected Persons on Dialysis, Journal of Clinical Gastroenterology, 2008, 42, 9, 1054

    CrossRef

  29. 29
    Samuel B. Ho, Erik Groessl, Adrian Dollarhide, Shannon Robinson, David Kravetz, Eric Dieperink, Management of Chronic Hepatitis C in Veterans: The Potential of Integrated Care Models, The American Journal of Gastroenterology, 2008, 103, 7, 1810

    CrossRef

  30. 30
    D. M. EVON, A. VERMA, K. SIMPSON, J. A. GALANKO, K. A. DOUGHERTY, M. W. FRIED, Psychiatric symptoms during interferon treatment for hepatitis C:experiences from a tertiary care hepatology centre, Alimentary Pharmacology & Therapeutics, 2008, 27, 11
  31. 31
    Mardge H. Cohen, Dennis Grey, Judith A. Cook, Kathryn Anastos, Eric Seaberg, Michael Augenbraun, Pam Burian, Marion Peters, Mary Young, Audrey French, Awareness of Hepatitis C Infection Among Women With and At Risk for HIV, Journal of General Internal Medicine, 2007, 22, 12, 1689

    CrossRef

  32. 32
    A. A. Butt, U. A. Khan, K. A. McGinnis, M. Skanderson, C. Kent Kwoh, Co-morbid medical and psychiatric illness and substance abuse in HCV-infected and uninfected veterans, Journal of Viral Hepatitis, 2007, 14, 12
  33. 33
    Karen H. Seal, Sue L. Currie, Hui Shen, Bhupinderjit S. Anand, Edmund J. Bini, Norbert Brau, Lennox Jeffers, Teresa L. Wright, Hepatitis C Treatment Candidacy and Outcomes Among 4318 US Veterans With Chronic Hepatitis C Virus Infection, Journal of Clinical Gastroenterology, 2007, 41, 2, 199

    CrossRef

  34. 34
    Donna M. Evon, Amit Verma, Karen A. Dougherty, Betty Batey, Mark Russo, Steven Zacks, Roshan Shrestha, Michael W. Fried, High Deferral Rates and Poorer Treatment Outcomes for HCV Patients with Psychiatric and Substance Use Comorbidities, Digestive Diseases and Sciences, 2007, 52, 11, 3251

    CrossRef

  35. 35
    Adrian W. Dollarhide, Catherine Loh, Susan G. Leckband, Rene Endow-Eyer, Shannon Robinson, Jonathan M. Meyer, Psychiatric Comorbidity Does Not Predict Interferon Treatment Completion Rates in Hepatitis C Seropositive Veterans, Journal of Clinical Gastroenterology, 2007, 41, 3, 322

    CrossRef

  36. 36
    Omar S. Khokhar, James H. Lewis, Reasons Why Patients Infected with Chronic Hepatitis C Virus Choose to Defer Treatment: Do They Alter Their Decision with Time?, Digestive Diseases and Sciences, 2007, 52, 5, 1168

    CrossRef

  37. 37
    Adeel A. Butt, Robert Evans, Melissa Skanderson, A. Obaid Shakil, Comorbid medical and psychiatric conditions and substance abuse in HCV infected persons on dialysis, Journal of Hepatology, 2006, 44, 5, 864

    CrossRef

  38. 38
    Shruti H Mehta, Gregory M Lucas, Lisa B Mirel, Michael Torbenson, Yvonne Higgins, Richard D Moore, David L Thomas, Mark S Sulkowski, Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic, AIDS, 2006, 20, 18, 2361

    CrossRef

  39. 39
    A. A. BUTT, A. C. JUSTICE, M. SKANDERSON, C. GOOD, C. K. KWOH, Rates and predictors of hepatitis C virus treatment in HCV–HIV-coinfected subjects, Alimentary Pharmacology & Therapeutics, 2006, 24, 4